Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Outcome of polycystic kidney disease patients on peritoneal dialysis: Systematic review of literature and meta-analysis.

Dupont V, Kanagaratnam L, Sigogne M, Bechade C, Lobbedez T, Portoles J, Rieu P, Drame M, Touré F.

PLoS One. 2018 May 22;13(5):e0196769. doi: 10.1371/journal.pone.0196769. eCollection 2018. Review.

2.

Residual Renal Function in Hemodialysis and Inflammation.

de Sequera P, Corchete E, Bohorquez L, Albalate M, Perez-Garcia R, Alique M, Marques M, García-Menéndez E, Portolés J, Ramirez R.

Ther Apher Dial. 2017 Dec;21(6):592-598. doi: 10.1111/1744-9987.12576. Epub 2017 Oct 3.

PMID:
28971592
3.

A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.

Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S.

Kidney Int. 2018 Feb;93(2):450-459. doi: 10.1016/j.kint.2017.06.022. Epub 2017 Sep 12.

PMID:
28911789
4.

Eculizumab in secondary atypical haemolytic uraemic syndrome.

Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M.

Nephrol Dial Transplant. 2017 Mar 1;32(3):466-474. doi: 10.1093/ndt/gfw453.

5.

Incorporating exposure to pitch canker disease to support management decisions of Pinus pinaster Ait. in the face of climate change.

Serra-Varela MJ, Alía R, Pórtoles J, Gonzalo J, Soliño M, Grivet D, Raposo R.

PLoS One. 2017 Feb 13;12(2):e0171549. doi: 10.1371/journal.pone.0171549. eCollection 2017.

6.

Midterm Results of Renal Transplantation From Controlled Cardiac Death Donors Are Similar to Those From Brain Death Donors.

Lafuente O, Sánchez-Sobrino B, Pérez M, López-Sánchez P, Janeiro D, Rubio E, Huerta A, Marques M, Llópez-Carratala MR, Rubio JJ, Portolés J.

Transplant Proc. 2016 Nov;48(9):2862-2866. doi: 10.1016/j.transproceed.2016.08.039.

PMID:
27932093
7.

Effect of balance Solution on the Peritoneal Membrane in Automated Peritoneal Dialysis.

De Los Ríos T, Pérez-Martínez J, Portoles J, Lichodziejewska-Niemierko M, Rivera M, Nowicki M, Książek A, Tato AM, Bohnhorst C, Feriani M.

Perit Dial Int. 2016 9-10;36(5):569-72. doi: 10.3747/pdi.2015.00010.

8.

Risk Factors for Clostridium Difficile Diarrhea in Patients With Solid Organ Transplantation.

Ramos A, Ortiz J, Asensio Á, Martínez-Ruiz R, Múñez E, Cantero M, Cozar A, Ussetti P, Portolés J, Cuervas-Mons V.

Prog Transplant. 2016 Sep;26(3):231-7. doi: 10.1177/1526924816655073. Epub 2016 Jun 28.

PMID:
27358344
9.

Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review.

Naesens M, Berger S, Biancone L, Crespo M, Djamali A, Hertig A, Öllinger R, Portolés J, Zuckermann A, Pascual J.

Nefrologia. 2016 Sep - Oct;36(5):469-480. doi: 10.1016/j.nefro.2016.03.019. Epub 2016 May 14. Review. English, Spanish.

10.

How should we analyze and present mortality in our patients?: A multicentre GCDP experience.

Janeiro D, Portolés J, Lopez-Sanchez P, Tornero F, Felipe C, Castellano I, Rivera M, Fernandez-Cusicanqui J, Cirugeda A, Fernandez-Reyes MJ, Rodriguez-Palomares JR, Bajo MA, Caparrós G, Ortiz A; Grupo Centro de Diálisis Peritoneal (GCDP) RedinRen.

Nefrologia. 2016;36(2):149-55. doi: 10.1016/j.nefro.2015.09.014. Epub 2016 Feb 3. English, Spanish.

11.

IgA nephropathy associated with acute interstitial nephritis after administering iodinated contrast media.

Valdenebro M, Marques M, Rubio E, Palomino E, García E, Fernández J, Huerta A, Bellas C, Portolés J.

Nefrologia. 2015 Nov-Dec;35(6):582-4. doi: 10.1016/j.nefro.2015.09.006. Epub 2015 Oct 23. English, Spanish. No abstract available.

12.

Peritoneal Dialysis Can Be an Option for Dominant Polycystic Kidney Disease: an Observational Study.

Janeiro D, Portolés J, Tato AM, López-Sánchez P, Del Peso G, Rivera M, Castellano I, Fernández-Reyes MJ, Pérez-Gómez V, Ortega M, Martínez-Miguel P, Felipe C, Caparrós G, Ortiz A, Selgas R; Grupo Centro de Diálisis Peritoneal (GCDP).

Perit Dial Int. 2015 Sep-Oct;35(5):530-6. doi: 10.3747/pdi.2014.00029. Epub 2014 Oct 7.

13.

Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study.

Cases A, Portolés J, Calls J, Martinez-Castelao A, Munar MA, Segarra A.

Int Urol Nephrol. 2014 Oct;46(10):1983-95. doi: 10.1007/s11255-014-0800-4. Epub 2014 Aug 14.

PMID:
25118611
14.

Application of the new cholesterol guidelines.

Gallegos-Villalobos A, Portolés J, Ortiz A.

N Engl J Med. 2014 Jul 3;371(1):77-8. doi: 10.1056/NEJMc1405680. No abstract available.

PMID:
24988563
15.

Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.

Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, Oliveras A, Portolés J, Rubio E, Segura J, Aranda P, de Francisco AL, Del Pino MD, Fernández-Vega F, Górriz JL, Luño J, Marín R, Martínez I, Martínez-Castelao A, Orte LM, Quereda C, Rodríguez-Pérez JC, Rodríguez M, Ruilope LM.

Nefrologia. 2014 May 21;34(3):302-16. doi: 10.3265/Nefrologia.pre2014.Feb.12464. Epub 2014 Mar 6. English, Spanish.

16.

Use of radioactive iodine I-131 and monitoring of radioactivity in patients with chronic kidney disease on haemodialysis.

Gallegos-Villalobos A, García-López F, Escalada C, Ortiz JJ, Cardona J, Medina A, Portolés J.

Nefrologia. 2014 May 21;34(3):317-22. doi: 10.3265/Nefrologia.pre2014.Jan.12442. Epub 2014 Feb 10. English, Spanish.

17.

Climate change scenarios for temperature and precipitation in Aragón (Spain).

Ribalaygua J, Pino MR, Pórtoles J, Roldán E, Gaitán E, Chinarro D, Torres L.

Sci Total Environ. 2013 Oct 1;463-464:1015-30. doi: 10.1016/j.scitotenv.2013.06.089. Epub 2013 Jul 20.

PMID:
23876546
18.

First episodes of peritoneal infection: description and prognostic factors.

Portolés J, Janeiro D, Lou-Arnal LM, López-Sánchez P, Ortega M, del Peso G, Felipe C, Tato AM, Velo M, Castellano I, Pérez-Díaz V; Grupo Centro de Diálisis Peritoneal (GCDP).

Nefrologia. 2013;33(3):316-24. doi: 10.3265/Nefrologia.pre2013.Feb.11733. English, Spanish.

19.

Implementation of clinical guidelines and compliance with target haemoglobin levels in peritoneal dialysis.

Portolés J, Gallegos-Villalobos Á, López-Gómez JM, de Valdenebro M, López-Sánchez P, Coronel F; Grupo Centro de Diálisis Peritoneal, RedinRen ISCIII (RED 06/0016).

Nefrologia. 2013 Jan 18;33(1):140-2. doi: 10.3265/Nefrologia.pre2012.Nov.11776. English, Spanish. No abstract available.

20.

The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease.

Portolés J, Gorriz JL, Rubio E, de Alvaro F, García F, Alvarez-Chivas V, Aranda P, Martinez-Castelao A; NADIR-3 Study Group.

BMC Nephrol. 2013 Jan 7;14:2. doi: 10.1186/1471-2369-14-2.

Supplemental Content

Loading ...
Support Center